Sleep apnea affects as many as 80 million in the U.S. Now Apnimed, the $400 million company behind the first ever pill to ...

Incannex Healthcare Inc. (Nasdaq: IXHL), a clinical-stage biopharmaceutical company developing innovative combination therapies, today announced that it has been honored with the Research and ...

Learn the hidden signs of sleep apnea, its impact on health, and how effective treatment can restore your energy and improve ...

A nightly oral pill for obstructive sleep apnea is close to regulatory approval in the US. This medicine-based option could ...

Obese patients with type 2 diabetes are less likely to need a CPAP machine to treat sleep apnea if they’re taking a GLP-1 ...

此前，北京安贞医院聂绍平等利用OSA-ACS项目数据进行研究后发现，对于中度/重度阻塞性睡眠呼吸暂停患者，尤其是夜间低氧血症患者，午夜至早晨6点是心梗的高发时段，提示该类患者应警惕夜间心梗。

Biotech firm Apnimed plans to seek FDA approval for its sleep apnea drug, with market availability expected by 2027 ...

Research also suggests untreated sleep apnea is linked to a heightened risk of Parkinsons disease, a movement disorder ...

You can live for years with obstructive sleep apnea and never know it. The condition repeatedly narrows your upper airway during sleep.

Medical News Today looks at three key studies and their key findings that highlight and further confirm the connection ...

Sleep apnea often goes untreated because it doesn’t look the way most people expect it to. Many imagine loud, disruptive ...